Funder will take loss in $7M QRxPharma class action settlement

Article 2020-09-23 3:04 pm By Miklos Bolza | Sydney

Please login to bookmark

The funder backing a shareholder class action against the directors of pharmaceutical firm QRxPharma will not seek to profit from a $7 million settlement in order to bring about a better return for group members, a judge has been told.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au